These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1903019

  • 1. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [Abstract] [Full Text] [Related]

  • 2. Effects of ritanserin on sleep disturbances of dysthymic patients.
    Paiva T, Arriaga F, Wauquier A, Lara E, Largo R, Leitao JN.
    Psychopharmacology (Berl); 1988 Apr; 96(3):395-9. PubMed ID: 3146774
    [Abstract] [Full Text] [Related]

  • 3. 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.
    Bersani G, Grispini A, Marini S, Pasini A, Valducci M, Ciani N.
    Clin Neuropharmacol; 1990 Dec; 13(6):500-6. PubMed ID: 2125857
    [Abstract] [Full Text] [Related]

  • 4. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S, Mohajari H, Reza Mohammadi M, Amini H.
    BMC Psychiatry; 2003 Jun 19; 3():7. PubMed ID: 12816549
    [Abstract] [Full Text] [Related]

  • 5. Study to establish the indication for the selective S2 antagonist ritanserin.
    Klieser E, Strauss WH.
    Pharmacopsychiatry; 1988 Nov 19; 21(6):391-3. PubMed ID: 3149751
    [Abstract] [Full Text] [Related]

  • 6. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D, Lapierre YD, Weinstein R, Klein J, Wiens A, Jones B, Horn E, Browne M, Bourget D, Blanchard A.
    J Clin Psychopharmacol; 1993 Dec 19; 13(6):409-14. PubMed ID: 8120154
    [Abstract] [Full Text] [Related]

  • 7. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM, Marini S, Gregori S.
    Int J Clin Pharmacol Res; 1987 Dec 19; 7(2):111-9. PubMed ID: 3108171
    [Abstract] [Full Text] [Related]

  • 8. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL, Hoppenbrouwers ML, Gelders YG, Reyntjens AJ.
    Pharmacopsychiatry; 1985 Sep 19; 18(5):303-5. PubMed ID: 3931107
    [Abstract] [Full Text] [Related]

  • 9. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W, Seibyl JP, D'Souza DC, Karper LP, Gueorgueva R, Abi-Dargham A, Wong ML, Rajhans S, Erdos JP, Heninger GR, Charney DS, Krystal JH.
    Psychopharmacology (Berl); 2002 Jun 19; 162(1):55-62. PubMed ID: 12107618
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM, Naylor GJ, Murtagh M, Winslow G.
    Acta Psychiatr Scand Suppl; 1989 Jun 19; 350():143-4. PubMed ID: 2530772
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Den Boer JA, Westenberg HG.
    Psychopharmacology (Berl); 1990 Jun 19; 102(1):85-94. PubMed ID: 1697419
    [Abstract] [Full Text] [Related]

  • 12. Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group.
    Wiesbeck GA, Weijers HG, Chick J, Naranjo CA, Boening J.
    Alcohol Clin Exp Res; 1999 Feb 19; 23(2):230-5. PubMed ID: 10069551
    [Abstract] [Full Text] [Related]

  • 13. Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.
    Bakish D, Ravindran A, Hooper C, Lapierre Y.
    Psychopharmacol Bull; 1994 Feb 19; 30(1):53-9. PubMed ID: 7972630
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul 19; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E, Pelicier Y, Archambault JC, Chabannes JP, Clerc G, Desvilles M, Guibert M, Pagot R, Poisat JL, Thobie Y.
    Acta Psychiatr Scand Suppl; 1989 Jul 19; 350():132-4. PubMed ID: 2530766
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder.
    Sramek JJ, Robinson RE, Suri A, Cutler NR.
    J Clin Psychopharmacol; 1995 Feb 19; 15(1):20-2. PubMed ID: 7714223
    [Abstract] [Full Text] [Related]

  • 17. A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    Acta Psychiatr Scand Suppl; 1989 Feb 19; 350():117-23. PubMed ID: 2530761
    [Abstract] [Full Text] [Related]

  • 18. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
    Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C.
    Psychopharmacology (Berl); 1996 Nov 19; 128(2):206-15. PubMed ID: 8956382
    [Abstract] [Full Text] [Related]

  • 19. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H, Rudolf GA.
    Acta Psychiatr Scand Suppl; 1989 Nov 19; 350():145-6. PubMed ID: 2530773
    [No Abstract] [Full Text] [Related]

  • 20. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr 19; 18(4):289-99. PubMed ID: 2140382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.